Orly Vardeny
Pharmacist · University of Minnesota
Credentials: ·
History
- Present
Research
Circulation · 2022 · 4,889 citations
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
New England Journal of Medicine · 2022 · 2,297 citations
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
New England Journal of Medicine · 2020 · 1,485 citations
- SS
129 papers
66 papers · 8 as a fellow
- AD
55 papers
33 papers
29 papers
26 papers · 8 as a fellow
- MK
24 papers
23 papers
Clinical trials
- 2017–2019
Comparing ARNI With ACE Inhibitor on Endothelial Function
Principal investigator · Withdrawn · Phase 4
Brigham and Women's Hospital
- 2016–2020
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Principal investigator · Completed · Phase 4
Brigham and Women's Hospital
- 2014–2016
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
Principal investigator · Completed · Phase 4
University of Wisconsin, Madison
- 2005–2007
Beta-2 Polymorphisms and Beta Receptor Selectivity
Principal investigator · Completed
University of Wisconsin, Madison